Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy

Bibliographic Details
Main Authors:	Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
Format:	Article
Language:	English
Published:	BMC 2023-01-01
Series:	Alzheimer’s Research & Therapy
Online Access:	https://doi.org/10.1186/s13195-022-01156-8

Similar Items

Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials
by: Jacqui Taryn Nimmo, et al.
Published: (2021-09-01)

AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies
by: Matthias Düchs, et al.
Published: (2023-06-01)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
by: Martin Kallab, et al.
Published: (2018-07-01)

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy
by: Omar El-Agnaf, et al.
Published: (2017-08-01)

α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies
by: Frederique J. Hart de Ruyter, et al.
Published: (2023-08-01)

Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
by: Jacob S. Deyell, et al.
Published: (2023-01-01)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
by: Inês C. Brás, et al.
Published: (2021-02-01)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
by: Alessandra Bigi, et al.
Published: (2023-01-01)

Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
by: Haya Kisos, et al.
Published: (2012-01-01)

A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies.
by: Jess-Karan S Dhillon, et al.
Published: (2017-01-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
by: Hazem Abdelkarim, et al.
Published: (2018-08-01)

Immunotherapies in Huntington's disease and α-Synucleinopathies
by: Oluwaseun Fatoba, et al.
Published: (2020-02-01)

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
by: Gaia Codolo, et al.
Published: (2013-01-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)

Solubility of α-synuclein species in the L62 mouse model of synucleinopathy
by: Karima Schwab, et al.
Published: (2024-03-01)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
by: Lee, S
Published: (2023)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
by: Arati Tripathi, et al.
Published: (2021-12-01)

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
by: Nahuai Badiola, et al.
Published: (2011-01-01)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
by: Changyoun Kim, et al.
Published: (2018-08-01)

In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
by: Maria Fouka, et al.
Published: (2020-09-01)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
by: Junghwan Shin, et al.
Published: (2020-01-01)

Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
by: Tritia R. Yamasaki, et al.
Published: (2020-05-01)

Calcium: alpha-synuclein interactions in alpha-synucleinopathies
by: Alexandre N. Rcom-H’cheo-Gauthier1, et al.
Published: (2016-12-01)

Biochemical Fractionation of Human α-Synuclein in a <i>Drosophila</i> Model of Synucleinopathies
by: Khondamir Imomnazarov, et al.
Published: (2024-03-01)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
by: An Cheng, et al.
Published: (2021-05-01)

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
by: Ying Xue Xie, et al.
Published: (2022-08-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies
by: Takehiro Nakagaki, et al.
Published: (2021-09-01)

Polypeptides derived from α-Synuclein binding partners to prevent α-Synuclein fibrils interaction with and take-up by cells.
by: Elodie Monsellier, et al.
Published: (2020-01-01)

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
by: Veronica Lindström, et al.
Published: (2014-09-01)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
by: Sindhu Menon, et al.
Published: (2022-05-01)

TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
by: Kaspar Russ, et al.
Published: (2021-03-01)

Assessment of α-Synuclein Pathology
by: Alafuzoff, I, et al.
Published: (2008)